Patrick Chung

Patrick Chung is a General Partner at Andreessen Horowitz in San Francisco, California, where he leads the bio and health fund. Managing over $2 billion in assets within a $7.1 billion bio portfolio, he directs early-stage investments across biotechnology, healthcare, and deep tech. His track record includes backing prominent companies like Ginkgo Bioworks and Freenome, and he recently led a $500 million funding round for a synthetic biology startup. Before entering the venture capital sector, Chung worked as an Associate at Bain & Company and served as an Editor of the Harvard Law Review. Holding advanced degrees from Harvard University and Oxford University, he also co-authored a 2023 artificial intelligence research paper published in Nature Biotechnology. His multidisciplinary background bridges environmental science, corporate law, and technological innovation, allowing him to focus on advancing transformative healthcare solutions.